Invention Grant
- Patent Title: Solabegron zwitterion and uses thereof
-
Application No.: US15332956Application Date: 2016-10-24
-
Publication No.: US10065922B2Publication Date: 2018-09-04
- Inventor: Raymond E. Stevens , Dalian Zhao , Bingidimi Itute Mobele
- Applicant: VELICEPT THERAPEUTICS, INC.
- Applicant Address: US PA Malvern
- Assignee: Velicept Therapeutics, Inc.
- Current Assignee: Velicept Therapeutics, Inc.
- Current Assignee Address: US PA Malvern
- Agency: Pepper Hamilton LLP
- Main IPC: C07C211/63
- IPC: C07C211/63 ; C07C229/52 ; A61K31/196 ; A61K45/06 ; C07C227/16 ; C07D233/26 ; C07D498/04
Abstract:
This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
Public/Granted literature
- US20170114005A1 Solabegron Zwitterion and Uses Thereof Public/Granted day:2017-04-27
Information query
